By Date


  • 20-September-2013

    English

    OECD countries address the safety of manufactured nanomaterials

    The OECD has recommended its Member Countries apply existing international and national chemical regulatory frameworks to manage the risks associated with manufactured nanomaterials.

    Related Documents
  • 4-September-2013

    English

    Marine Biotechnology: Enabling Solutions for Ocean Productivity and Sustainability

    This book discusses scientific and technological tools at the centre of a renewed interest in marine biotechnology that is contributing to a new bioeconomy sector in many countries and offering potential new solutions to global challenges.

    Related Documents
  • 2-August-2013

    English

    Public Health in an Age of Genomics

    This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.

    Related Documents
  • 11-July-2013

    English

    OECD Communications Outlook 2013

    Published every two years, the OECD Communications Outlook provides an extensive range of indicators for the development of different communications networks and compares performance indicators such as  revenue, investment, employment and prices for service throughout the OECD area. These indicators are essential for industry and regulators who use benchmarking to evaluate policy performance.

    This edition is based on data

  • 11-July-2013

    English

    More competition essential for future of mobile innovation, says OECD

    OECD countries must ensure mobile markets remain open and competitive in order to sustain innovation and meet rising demand for data services, according to a new OECD report.

    Related Documents
  • 18-June-2013

    English

    Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer's

    The economic and social impact of chronic brain disorders such as Alzheimer’s and other neurodegenerative diseases will become the #1 public health problem worldwide by 2050, directly affecting 100 million people. Ongoing demographic trends, namely ageing populations, are leading to the unprecedented expansion of consumer demand for healthcare services, which will confront a serious crisis in a climate of shrinking resources.

    Related Documents
  • 14-June-2013

    English

    Nanotechnology for Green Innovation

    This paper brings together information collected through Working Party on Nanotechnology discussions and projects. It relies in particular on preliminary results from a project on the responsible development of nanotechnology and outcomes of a symposium held in 2012.

    Related Documents
  • 5-June-2013

    English

    Innovation: the next frontier?

    The growing food security and poverty challenges that we face deserve our special attention. Experience has shown that only through sharing best practices and lessons learned can we develop more targeted policies and coordinate our efforts at promoting agricultural development through innovation, said Angel Gurría, OECD Secretary-General.

    Related Documents
  • 28-May-2013

    English

    Interconnected Economies - Benefiting from Global Value Chains

    Global Value Chains (GVCs) have exploded in the past decade and refer to the international dispersion of design, production, assembly, marketing and distribution of services, activities, and products. Different stages in the production process are increasingly located across different economies, and intermediate inputs like parts and components are produced in one country and then exported to other countries for further production

  • 25-April-2013

    English

    Regulatory Frameworks for Nanotechnology in Foods and Medical Products: Summary Results of a Survey Activity

    Countries/regions have begun to develop and refine regulatory approaches for foods and medical products and invest in regulatory science and other research efforts to support the responsible development of nanotechnology in these areas. This paper inventories and analyses regulatory approaches, legislative regimes and government-sponsored research programmes and infrastructure in foods and medical products that involve nanotechnology.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>